Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGrail expected to be first FDA-approved multi-cancer test, says CEO Bob RagusaGrail CEO Bob Ragusa joins CNBC's 'Squawk Box' to discuss the company's debut on the Nasdaq, how Grail is innovating early cancer detection, and more.

---

Persons: Bob Ragusa Organizations: FDA, Nasdaq Locations: CNBC's